Aug 10, 2026 6:30am EDT Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
Aug 4, 2026 8:30am EDT Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss
August 12, 2026 2:00 pm EDT – 2:25 pm EDT Canaccord Genuity's 46th Annual Growth Investors Conference